Dairy Choline Bioavailability
Part of paid clinical trials in Madison, Wisconsin.
- Sponsor
- University of Wisconsin, Madison
- Study ID
- NCT06902480
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Post-menopausal Status
- Post-menopausal Women
Eligibility Criteria
- Sex
- FEMALE
- Age
- 51 Years - 70 Years
- Healthy Volunteers
- Accepted
Interventions
- WPPC — DIETARY_SUPPLEMENTA chocolate-flavored drink with WPPC added
- Whole egg powder — DIETARY_SUPPLEMENTA chocolate-flavored drink with whole egg powder added
Study Details
The goal of this clinical trial is to find out if dairy is a good source of choline compared to eggs. The main questions it aims to answer are: * How the body uses choline; and, * What effect WPPC has on choline metabolism. Researchers will compare Whey Protein Phospholipid Concentrate (WPPC) to whole egg powder to see if WPPC is as effective as eggs. Participants will drink a chocolate-flavored drink mixed with either WPPC or whole egg powder.
Key Dates
- Start date
- Jul 31, 2026
- Status verified
- Oct 2025
- Primary completion
- Apr 30, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 24 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Experimental: Whey Protein Phospholipid Concentrate (WPPC)Participants will drink a chocolate-flavored drink with WPPC added
- Experimental: Pasteurized whole egg powderParticipants will drink a chocolate-flavored drink with egg powder added
Primary Outcome Measure
Change in circulating choline [ Time Frame: Baseline to 10 days ]
Central Contacts
- Kevin Shih919-338-9453
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Wisconsin - Madison | Madison | Wisconsin | 53705 | Kevin Shih Bradley Bolling, PhD (PRINCIPAL_INVESTIGATOR) |